Showing results (21-30 of 153) with videos related to
Sort By:
Pageof 16
Cancer Research|March 1, 1984
Impairment of concanavalin A-inducible suppressor activity following administration of cyclophosphamide to patients with advanced cancerD Berd, H C Maguire, M J MastrangeloCancer Research|December 1, 1989
Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigensD Berd, M Herlyn, H Koprowski, et al.Cancer|December 15, 1990
The role of autologous tumor cells in preventing lymphokine-activated killer cell induction in vitroS F Slovin, H C Maguire, M J MastrangeloCellular and Molecular Biology (Noisy-Le-Grand, France)|July 31, 2003
Aerosolized substance P protects against cigarette-induced lung damage and tumor developmentD T Harris, M WittenJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patientsD Berd, H C Maguire, P McCue, et al.Cancer Research|May 15, 1991
Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastasesD Berd, G Murphy, H C Maguire, et al.Cancer|January 5, 2000
Paclitaxel and tamoxifen: An active regimen for patients with metastatic melanomaF E Nathan, D Berd, T Sato, et al.Journal of the National Cancer Institute|November 1, 1979
Evaluation of a "nude" mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agentsR E Bellet, V Danna, M J Mastrangelo, et al.Clinical Immunology and Immunopathology|January 1, 1995
Human immune response to DNP-modified autologous cells after treatment with a DNP-conjugated melanoma vaccineT Sato, H C Maguire, M J Mastrangelo, et al.Cancer Immunology, Immunotherapy : CII|September 1, 1994
Activation markers on T cells infiltrating melanoma metastases after therapy with dinitrophenyl-conjugated vaccineD Berd, H C Maguire, M J Mastrangelo, et al.Pageof 16